Osteopontin (OPN) facilitates bone metastasis in breast cancer and PCa and generates 3 AS variants: OPN-a (full-length), OPN-b (lacking exon 5), and OPN-c (lacking exon 4) [256,257]. Here, SPP1 is linked to breast cancer.